Company profile: Organ Transport Systems
1.1 - Company Overview
Company description
- Provider of portable, hypothermic, oxygenated preservation and transport technology for human organs, offering the LifeCradle HR durable perfusion unit and a complementing single-use organ chamber and fluid circuit kit.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Organ Transport Systems
XVIVO Perfusion
HQ: Sweden
Website
- Description: Provider of medical technology solutions for organ, tissue, and cell preservation in transplantation, offering the XPS ex‑vivo lung perfusion system, Kidney Assist Transport for hypothermic pulsatile perfusion, Liver Assist protocols, PERFADEX Plus lung preservation solution, and the XVIVO Academy to improve transplant outcomes and support transplant teams.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full XVIVO Perfusion company profile →
Essential Pharma
HQ: United States
Website
- Description: Provider of new tools for medical researchers and manufacturers to bring performance, convenience, and control to the advancement of basic research and drug discovery, supporting the preservation and growth of human systems from the cell to the entire organ. Based in Ewing, NJ.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Essential Pharma company profile →
TransMedics
HQ: United States
Website
- Description: Provider of organ preservation technology and clinical service solutions for transplantation, offering OCS Heart, OCS Lung, and OCS Liver systems that keep donor organs functional for viability assessment and transport; the National OCS Program with technology, clinical services, and training; and the OCS Lung Solution for flushing, storage, and transportation.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full TransMedics company profile →
Paragonix Technologies
HQ: United States
Website
- Description: Provider of organ preservation and transport systems for heart, lung, and liver transplantation, including FDA-cleared SherpaPak Cardiac Transport System and LUNGguard, LIVERguard for static hypothermic liver preservation, and BAROguard with automated pressure regulation, plus a digital app for real-time location and temperature tracking and 24/7 clinical support for procurement and organ delivery.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Paragonix Technologies company profile →
SQI Diagnostics
HQ: Canada
Website
- Description: Provider of medical systems and diagnostics leveraging proprietary multiplexing, miniaturization, and automation; offerings include RALI-Dx IL-6 Severity Triage for COVID-19, rapid mobile PCR testing, Sofia SARS Antigen FIA, Sofia2 Flu+SARS Antigen FIA, QuickVue At-Home OTC COVID-19 test, and the TORdx LUNG test under development to assess donor lung health.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full SQI Diagnostics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Organ Transport Systems
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Organ Transport Systems
2.2 - Growth funds investing in similar companies to Organ Transport Systems
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Organ Transport Systems
4.2 - Public trading comparable groups for Organ Transport Systems
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →